Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer, Invasive Ductal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04750473
What this trial is testing

Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast Lobular CarcinomaMetastatic Breast Lobular Carcinoma+1 more
Emory University 20
Large-scale testing (Phase 3)Active Not RecruitingNCT01905046
What this trial is testing

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaBRCA1 Mutation CarrierBRCA2 Mutation Carrier+2 more
Alliance for Clinical Trials in Oncology 86
Large-scale testing (Phase 3)Study completedNCT00002920
What this trial is testing

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

Who this might be right for
Breast CancerEndometrial Cancer
SWOG Cancer Research Network 313
Not applicableStudy completedNCT01407770
What this trial is testing

Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer

Who this might be right for
Breast CancerCognitive Ability, GeneralFatigue+4 more
Wake Forest University Health Sciences 1,000
Testing effectiveness (Phase 2)Ended earlyNCT02127073
What this trial is testing

Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
Montefiore Medical Center 8
Not applicableUnknownNCT00967239
What this trial is testing

Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,881
Not applicableEnded earlyNCT02023008
What this trial is testing

Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation Therapy

Who this might be right for
Anxiety DisorderDepressionDuctal Breast Carcinoma in Situ+7 more
Wake Forest University Health Sciences 6
Not applicableStudy completedNCT05086705
What this trial is testing

EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer

Who this might be right for
Breast CarcinomaBreast Ductal Carcinoma In SituBreast Lobular Carcinoma In Situ+1 more
Ohio State University Comprehensive Cancer Center 50
Not applicableStudy completedNCT00666731
What this trial is testing

Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer

Who this might be right for
Breast CancerPrecancerous Condition
University of Nebraska 4,945
Not applicableWithdrawnNCT00041353
What this trial is testing

Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer

Who this might be right for
Breast Cancer
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT00616967
What this trial is testing

Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 68
Large-scale testing (Phase 3)Active Not RecruitingNCT03414970
What this trial is testing

Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer

Who this might be right for
Ductal Breast CarcinomaInvasive Breast CarcinomaLobular Breast Carcinoma+6 more
Alliance for Clinical Trials in Oncology 898
Not applicableStudy completedNCT00182728
What this trial is testing

Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 89
Testing effectiveness (Phase 2)Study completedNCT00960336
What this trial is testing

Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
ARCAGY/ GINECO GROUP 59
Testing effectiveness (Phase 2)Study completedNCT00182793
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 32
Not applicableLooking for participantsNCT06350500
What this trial is testing

A Patient Navigation Program for Addressing Disparities in Breast Cancer Care

Who this might be right for
Breast CarcinomaBreast Ductal Carcinoma in Situ
Roswell Park Cancer Institute 126
Not applicableStudy completedNCT00804128
What this trial is testing

Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)

Who this might be right for
Breast Cancer
University of California, San Francisco 76
Not applicableUnknownNCT00935233
What this trial is testing

Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy Volunteers

Who this might be right for
Breast Cancer
Queen Mary University of London 6,000
Testing effectiveness (Phase 2)WithdrawnNCT01100489
What this trial is testing

Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituEstrogen Receptor-negative Breast CancerEstrogen Receptor-positive Breast Cancer+13 more
Case Comprehensive Cancer Center
Not applicableUnknownNCT02909426
What this trial is testing

The Mammography and Ultrasonography STudy for Breast Cancer Screening Effectiveness

Who this might be right for
Invasive CancerDuctal Carcinoma in Situ
Soonchunhyang University Hospital 11,880
Next Page